title: Plasma hepatocyte growth factor levels after open heart surgery for congenital heart disease.
abstract: BACKGROUND
  Hepatocyte growth factor (HGF) is a polypeptide which acts protectively against endothelial cell dysfunction. A high plasma level of HGF is shown when the endothelium is injured. We measured plasma HGF levels during and after open heart operations for congenital heart disease, to elucidate its involvement with endothelial cell injury.
  
  
  METHODS
  
  
  
  METHODS
  prospective study.
  
  
  METHODS
  perioperative setting.
  
  
  METHODS
  18 children electively operated upon for congenital heart disease using CPB.
  
  
  RESULTS
  Plasma HGF levels (ng/ml) before cardiopulmonary bypass (CPB) were 0.36+/-0.07 in 10 children (S-group) who were older and with simpler diseases, and 0.48+/-0.12 in 8 children (C-group) who were younger and with relatively complex diseases. HGF levels significantly increased after CPB, and gradually decreased thereafter. Plasma HGF levels 3 and 6 hours after CPB were significantly greater in the C-group than in the S-group (1.13+/-0.12 vs 1.68+/-0.1 6 3 hours after, and 1.09+/-0.19 vs 2.35+/-0,43 6 hours after; p<0.05 for both). There were significant positive correlations between HGF levels 6 hours after CPB and the duration of the CPB, the aortic crossclamping time, and plasma thrombomodulin levels just after CPB in all patients (p<0.05 for all).
  
  
  CONCLUSIONS
  This data suggests that increased HGF levels are associated with endothelial cell injury induced by CPB, and that the increases are much greater in younger patients with complex anomalies.
authors.affiliation: Department of Thoracic and Cardiovascular Surgery, Wakayama Medical College, Kimiidera, Wakayama, Japan. komaih@mail.wakayama-med.ac.jp
authors.forename: H
authors.initials: H
authors.lastname: Komai
authors.forename: Y
authors.initials: Y
authors.lastname: Naito
authors.forename: K
authors.initials: K
authors.lastname: Fujiwara
mesh_terms: D015415:Biomarkers / Q000097:blood; D002315:Cardiopulmonary Bypass / Q000379:methods*; D002648:Child; D002675:Child, Preschool; D015331:Cohort Studies; D004730:Endothelium, Vascular / Q000473:pathology*; D005260:Female; D005500:Follow-Up Studies; D006330:Heart Defects, Congenital / Q000175:diagnosis / Q000601:surgery*; D017228:Hepatocyte Growth Factor / Q000097:blood*; D006801:Humans; D008297:Male; D011184:Postoperative Period; D011300:Preoperative Care; D011336:Probability; D011446:Prospective Studies; D012680:Sensitivity and Specificity; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D015415:Biomarkers; D017228:Hepatocyte Growth Factor